Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

MAOIs and transdermal delivery.

Vandenberg CM.

J Clin Psychiatry. 2012 Sep;73(9):e28. doi: 10.4088/JCP.11096tx6c.

2.

The transdermal delivery system of monoamine oxidase inhibitors.

VanDenBerg CM.

J Clin Psychiatry. 2012;73 Suppl 1:25-30. doi: 10.4088/JCP.11096su1c.04. Review.

3.

Transdermal selegiline.

Patkar AA, Pae CU, Zarzar M.

Drugs Today (Barc). 2007 Jun;43(6):361-77. Review.

PMID:
17612708
4.

MAOIs and depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012 Jul;73(7):e24. doi: 10.4088/JCP.11096tx4c.

5.

Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.

Flockhart DA.

J Clin Psychiatry. 2012;73 Suppl 1:17-24. doi: 10.4088/JCP.11096su1c.03. Review.

6.

The role of monoamine oxidase inhibitors in depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012;73 Suppl 1:10-6. doi: 10.4088/JCP.11096su1c.02.

7.

Translating the evidence on atypical depression into clinical practice.

Hyman Rapaport M.

J Clin Psychiatry. 2007;68 Suppl 3:31-6. Review.

8.

The use of MAOIs in primary care.

Culpepper L.

J Clin Psychiatry. 2012 May;73(5):e19. doi: 10.4088/JCP.11096tx8c.

9.

Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

Patkar AA, Pae CU, Masand PS.

CNS Spectr. 2006 May;11(5):363-75. Review.

PMID:
16641841
10.

Current place of monoamine oxidase inhibitors in the treatment of depression.

Shulman KI, Herrmann N, Walker SE.

CNS Drugs. 2013 Oct;27(10):789-97. doi: 10.1007/s40263-013-0097-3. Review.

PMID:
23934742
11.

Monoamine oxidase inhibitors: a new generation.

Robinson DS.

Psychopharmacol Bull. 2002 Summer;36(3):124-38.

PMID:
12473970
12.

The use of monoamine oxidase inhibitors in primary care.

Culpepper L.

J Clin Psychiatry. 2012;73 Suppl 1:37-41. doi: 10.4088/JCP.11096su1c.06. Review.

13.

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2012;73 Suppl 1:31-6. doi: 10.4088/JCP.11096su1c.05. Review.

14.

Selegiline transdermal system: current awareness and promise.

Pae CU, Lim HK, Han C, Neena A, Lee C, Patkar AA.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1153-63. Epub 2007 May 10. Review.

PMID:
17614182
15.
16.

Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants.

Stahl SM, Felker A.

CNS Spectr. 2008 Oct;13(10):855-70. Review.

PMID:
18955941
17.

Monoamine oxidase inhibitors. A perspective on their use in the elderly.

Volz HP, Gleiter CH.

Drugs Aging. 1998 Nov;13(5):341-55. Review.

PMID:
9829163
18.

Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.

Thomas SJ, Shin M, McInnis MG, Bostwick JR.

Pharmacotherapy. 2015 Apr;35(4):433-49. doi: 10.1002/phar.1576. Review.

19.

Moclobemide: therapeutic use and clinical studies.

Bonnet U.

CNS Drug Rev. 2003 Spring;9(1):97-140. Review.

20.

Revisiting monoamine oxidase inhibitors.

Krishnan KR.

J Clin Psychiatry. 2007;68 Suppl 8:35-41. Review.

Supplemental Content

Support Center